Intronn, Inc.
Records under this name other than patents Intronn, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,929,907 | Methods and compositions for determining the purity of chemically synthesized nucleic acids Formerly held Term ended Term ended Jan 20, 2020 · From the USPTO record | Term ended | Term ended Jan 20, 2020 | From the USPTO record |
| US 8,053,232 | Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing Formerly held Lapsed on the fee record Ended Nov 8, 2019 · From the USPTO record | Lapsed on the fee record | Ended Nov 8, 2019 | From the USPTO record |
| US 7,968,334 | Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing Formerly held Lapsed on the fee record Ended Jun 28, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jun 28, 2019 | From the USPTO record |
| US 7,879,321 | Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production Formerly held Lapsed on the fee record Ended Feb 1, 2019 · From the USPTO record | Lapsed on the fee record | Ended Feb 1, 2019 | From the USPTO record |
| US 7,871,795 | Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins Formerly held Lapsed on the fee record Ended Jan 18, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jan 18, 2019 | From the USPTO record |
| US 8,883,753 | Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing Formerly held Lapsed on the fee record Ended Nov 11, 2018 · From the USPTO record | Lapsed on the fee record | Ended Nov 11, 2018 | From the USPTO record |
| US 6,280,978 | Methods and compositions for use in spliceosome mediated RNA trans-splicing Formerly held Term ended Term ended Sep 23, 2018 · From the USPTO record | Term ended | Term ended Sep 23, 2018 | From the USPTO record |
| US 7,094,399 | Use of spliceosome mediated RNA trans-splicing to confer cell selective replication to adenoviruses Formerly held Lapsed on the fee record Ended Aug 22, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 22, 2018 | From the USPTO record |
| US 6,083,702 | Methods and compositions for use in spliceosome mediated RNA trans-splicing Formerly held Term ended Term ended Aug 13, 2018 · From the USPTO record | Term ended | Term ended Aug 13, 2018 | From the USPTO record |
| US 6,013,487 | Chimeric RNA molecules generated by trans-splicing Formerly held Term ended Term ended Dec 13, 2016 · From the USPTO record | Term ended | Term ended Dec 13, 2016 | From the USPTO record |